Compare

Compare archived captures

This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.

Descriptive changes only

This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.

Need to cite this comparison? See /cite.

Earlier capture

MedEffect Canada - Canada.ca

Apr 18, 2025

legacy-hc-2025-04-21

ID 168598

Later capture

MedEffect Canada - Canada.ca

Jan 2, 2026

hc-20260101

ID 428946

updated2 sections changed; 1 added
2 sections changed1 added0 removed+6 / -3 linesChange ratio: 11%
---
+++
@@ -9,7 +9,11 @@
Reports and Publications
As part of its regulatory responsibility, Health Canada conducts consultations in the area of post-market surveillance. Participants' comments and ideas contribute to the development of strategic priorities for these programs, helping us define what they should strive to achieve in the short, medium and long-term.
Current Consultations
-There are no current consultations.
+2025
+Consultation: Draft guidance on preparing and submitting summary reports for marketed drugs and natural health products
+[2025-10-24]
+Consultation for guidance on notifying Health Canada of foreign actions
+[2025-09-25]
Past Consultations
2021
Consultation: Reporting adverse reactions to marketed health products – Draft guidance document for industry
@@ -36,5 +40,4 @@
Marketed Health Products Directorate
.
Page details
-Date modified:
-2021-04-27
+2025-10-24